Nephrotoxicity Risk of Cyclophosphamide in Lupus Model
Cyclophosphamide is one of the standard therapies for lupus, especially lupus nephritis based on its immunosuppressive effect. However, cyclophosphamide is also known as a nephrotoxic agent. Therefore, this research was aimed to measure the effect of cyclophosphamide at the dose that comparable to t...
Saved in:
Main Author: | Niken Indriyanti (Author) |
---|---|
Format: | Book |
Published: |
Mulawarman University,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Minireview: Prospect of Doxycycline in Systemic Lupus Erythematosus Treatment
by: Niken Indriyanti, et al.
Published: (2019) -
Genetic Polymorphisms Associated with Cyclophosphamide Outcome and Risk of Toxicity in Patients with Lupus Nephritis
by: Yen Yen Ari Indrawijaya, et al.
Published: (2023) -
Protective Effect of Croton macrostachyus (Euphorbiaceae) Stem Bark on Cyclophosphamide-Induced Nephrotoxicity in Rats
by: Ayza MA, et al.
Published: (2020) -
Ameliorative effects of hydroalcoholic extract of Lavandula officinalis L. on cyclophosphamide-induced nephrotoxicity in mice
by: Ali Sadeghi, et al.
Published: (2017) -
Efficacy of high-dose methylprednisolone and cyclophosphamide in childhood-onset systemic lupus erythematosus
by: Putu Ayunda Trisnia, et al.
Published: (2020)